Bush Jennifer sold $75K of ARTV
Bush Jennifer (COO, CLO, Compliance Officer) sold 19,217 shares of Artiva Biotherapeutics, Inc. (ARTV) at $3.91 on 2026-11-17.
How this was made
The 30-second read
Why it matters
This is a primary disclosure of an insider open-market sale by the COO/CLO/Compliance Officer, which can slightly affect sentiment but does not change company fundamentals on its own.
Market read
Traders may monitor for additional insider activity, but the filing alone is unlikely to drive a sustained repricing.
What to watch
No 10b5-1 plan is stated, but Form 4 insider sales are often non-informational; without concurrent buys or guidance changes, price impact is usually muted.
Background
The article reports an SEC Form 4 insider transaction for Artiva Biotherapeutics, Inc. (ARTV).
Ticker impact
Artiva Biotherapeutics COO Jennifer Bush sold 19,217 shares in an open-market transaction for about $75,175, per a fresh SEC Form 4 filing.
Likely limited near-term impact, with traders treating it as routine insider activity unless follow-on selling accelerates.
The article is a primary-source Form 4 showing an open-market sale, with no 10b5-1 plan and no accompanying company-specific operational or financial update.
Market effects
Minimal, as this is a single-company insider transaction with no sector-wide regulatory or clinical signal.
None.
None.
Counterpoint
The sale may reflect diversification, taxes, or pre-planned personal liquidity needs, especially since the filing does not indicate any operational deterioration.
Key entities
- issuerArtiva Biotherapeutics, Inc.
Subject of the Form 4 insider transaction disclosed in the article.
- insiderJennifer Bush
COO, CLO, and Compliance Officer who sold shares via an open-market sale.



